BIGH3 A pharmaceutical composition for inhibiting cancer metastasis using regulation of BIGH3

摘要

The present invention relates to a pharmaceutical composition for inhibiting cancer metastasis through modulation of BIGH3 protein. The pharmaceutical composition of the present invention has a great effect on the inhibition of cancer metastasis to primary organs, and thus it is expected to be greatly utilized in cancer treatment field.